August 29, 2025

LHON UK Treatment Approved

NICE approves first treatment for Leber’s hereditary optic neuropathy in England

The Ophthalmologist

August 28, 2025

XENIA: A Natural Solution

Experts discuss six years of keratoconus treatment with the XENIA corneal implant

The Ophthalmologist

August 28, 2025

IDE Clearance for Calibreye System

Myra Vision gains FDA clearance to begin US IDE study of adjustable glaucoma shunt

The Ophthalmologist

August 13, 2025

Ozempic and Vision

Understanding recent updates to the risks associated with semaglutide

The Ophthalmologist

August 12, 2025

Exonate Initiates Phase IIb Trial of EXN407 for Diabetic Eye Disease

EXN407 is the first topical SRPK1 inhibitor to demonstrate safety and efficacy as a monotherapy for non-proliferative diabetic retinopathy (NPDR) and diabetic macular edema

The Ophthalmologist

August 08, 2025

Also in the News…

The Ophthalmologist brings you the top news stories and studies of the week

The Ophthalmologist

August 08, 2025

Phase III Data on Bausch + Lomb's LUMIFY®

Publication of phase III data on LUMIFY® preservative-free redness reliever eye drops

The Ophthalmologist

August 07, 2025

Laser-Induced Polymer Fragmentation in IOLs

Even with the finest skills, technique, devices and experience, performance suffers when clarity is compromised

The Ophthalmologist

August 07, 2025

Glaucoma UK Names 2025 Grant Winners

Three glaucoma projects share a grant total of just under £240,000

The Ophthalmologist